Cargando…

Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure

Chronic heart failure (CHF) represents a major cause of hospitalization and death. Recent evidence shows that novel biomarkers such as soluble suppression of tumorigenicity (sST2), growth-differentiation factor-15 (GDF-15), soluble urokinase plasminogen activator receptor (suPAR) and heart-type fatt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jirak, Peter, Fejzic, Dzeneta, Paar, Vera, Wernly, Bernhard, Pistulli, Rudin, Rohm, Ilonka, Jung, Christian, Hoppe, Uta C, Schulze, P Christian, Lichtenauer, Michael, Yilmaz, Atilla, Kretzschmar, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289366/ https://www.ncbi.nlm.nih.gov/pubmed/29239349 http://dx.doi.org/10.1038/aps.2017.167

Ejemplares similares

Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls
por: Jirak, Peter, et al.
Publicado: (2020)

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016)

Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction
por: Schernthaner, Christiana, et al.
Publicado: (2017)

Autoimmune myocarditis is not associated with left ventricular systolic dysfunction
por: Mirna, Moritz, et al.
Publicado: (2019)

sST2 Levels Show No Association with Helicobacter pylori Infection in Asymptomatic Patients: Implications for Biomarker Research
por: Wernly, Sarah, et al.
Publicado: (2023)

Characterization of dendritic cells in human and experimental myocarditis
por: Pistulli, Rudin, et al.
Publicado: (2020)

Disease-specific characteristics of vascular cell adhesion molecule-1 levels in patients with peripheral artery disease
por: Edlinger, Christoph, et al.
Publicado: (2018)

Assessment of Cardiac Remodeling—A Chance for Novel Cardiac Biomarkers?
por: Jirak, Peter, et al.
Publicado: (2020)

SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
por: Zagidullin, Naufal, et al.
Publicado: (2023)

Decrease in Circulating Dendritic Cell Precursors in Patients with Peripheral Artery Disease
por: Kretzschmar, Daniel, et al.
Publicado: (2015)

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia
por: Fiedler, Lukas, et al.
Publicado: (2022)

Tumor necrosis factor alpha—an underestimated risk predictor in patients undergoing transcatheter aortic valve replacement (TAVR)?
por: Mirna, Moritz, et al.
Publicado: (2021)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Partial oral antibiotic therapy is non-inferior to intravenous therapy in non-critically ill patients with infective endocarditis: Review and meta-analysis
por: Rezar, Richard, et al.
Publicado: (2020)

Decreased Regulatory T Cells in Vulnerable Atherosclerotic Lesions: Imbalance between Pro- and Anti-Inflammatory Cells in Atherosclerosis
por: Rohm, Ilonka, et al.
Publicado: (2015)

Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study
por: Rezar, Richard, et al.
Publicado: (2021)

New Cardiovascular Biomarkers in Ischemic Heart Disease—GDF-15, A Probable Predictor for Ejection Fraction
por: Dalos, Daniel, et al.
Publicado: (2019)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Heart-Type Fatty Acid-Binding Protein (H-FABP) and Its Role as a Biomarker in Heart Failure: What Do We Know So Far?
por: Rezar, Richard, et al.
Publicado: (2020)

Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
por: Paar, Vera, et al.
Publicado: (2020)

Carcinoid heart disease involving the left heart: a case report and biomarker analysis
por: Lichtenauer, Michael, et al.
Publicado: (2019)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
por: Jirak, Peter, et al.
Publicado: (2021)

Dynamic Changes of Heart Failure Biomarkers in Response to Parabolic Flight
por: Jirak, Peter, et al.
Publicado: (2020)

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine
por: Ohnewein, Bernhard, et al.
Publicado: (2023)

Myocardial injury in severe COVID‐19 is similar to pneumonias of other origin: results from a multicentre study
por: Jirak, Peter, et al.
Publicado: (2020)

Visualization and appearance of artifacts of leadless pacemaker systems in cardiac MRI: An experimental ex vivo study
por: Edlinger, Christoph, et al.
Publicado: (2018)

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
por: Motloch, Lukas J., et al.
Publicado: (2022)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Echokardiographieuntersuchungen in Zeiten der COVID-19-Pandemie: Internationale Empfehlungen und Umsetzung
por: Lichtenauer, Michael, et al.
Publicado: (2020)

Conundrum of Classifying Subtypes of Pulmonary Hypertension—Introducing a Novel Approach to Classify “Borderline” Patients in a Population with Severe Aortic Stenosis Undergoing TAVI
por: Boxhammer, Elke, et al.
Publicado: (2022)

Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
por: Kuster, Nils, et al.
Publicado: (2020)

MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?
por: Mirna, Moritz, et al.
Publicado: (2019)

Novel Biomarkers in Patients with Chronic Kidney Disease: An Analysis of Patients Enrolled in the GCKD-Study
por: Mirna, Moritz, et al.
Publicado: (2020)

Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
por: Rohm, Ilonka, et al.
Publicado: (2017)

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
por: Rezar, Richard, et al.
Publicado: (2022)

Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance
por: Wernly, Bernhard, et al.
Publicado: (2017)

Differential Impact of Hyperglycemia in Critically Ill Patients: Significance in Acute Myocardial Infarction but Not in Sepsis?
por: Wernly, Bernhard, et al.
Publicado: (2016)

Hyperlactatemia and altered lactate kinetics are associated with excess mortality in sepsis: A multicenter retrospective observational study
por: Rezar, Richard, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tug6ko3236rff8a8vgeqs63i24